Eagle Harbor Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Eagle Harbor Asset Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$763K	Sell	3,166 -146	-4%	-$32K	0.6%	49
2026 Q1	$626K	Hold	3,312	–	–	0.54%	57
2025 Q4	$563K	Sell	3,312 -40	-1%	-$6.13K	0.47%	64
2025 Q3	$442K	Sell	3,352 -294	-8%	-$35.3K	0.38%	81
2025 Q2	$387K	Sell	3,646 -65	-2%	-$7.06K	0.37%	88
2025 Q1	$461K	Sell	3,711 -400	-10%	-$52.2K	0.47%	74
2024 Q4	$506K	Sell	4,111 -290	-7%	-$34.2K	0.51%	61
2024 Q3	$490K	Buy	4,401 +618	+16%	+$67.7K	0.49%	70
2024 Q2	$404K	Sell	3,783 -10	-0.3%	-$1.1K	0.43%	75
2024 Q1	$457K	Sell	3,793 -295	-7%	-$36.1K	0.48%	68
2023 Q4	$503K	Sell	4,088 -568	-12%	-$70.9K	0.58%	57
2023 Q3	$603K	Buy	4,656 +378	+9%	+$50.4K	0.79%	37
2023 Q2	$530K	Buy	4,278 +194	+5%	+$26.1K	0.69%	47
2023 Q1	$598K	Sell	4,084 -57	-1%	-$8.43K	0.81%	41
2022 Q4	$660K	Sell	4,141 -405	-9%	-$59.4K	0.97%	35
2022 Q3	$606K	Sell	4,546 -98	-2%	-$14.9K	1.04%	32
2022 Q2	$725K	Sell	4,644 -264	-5%	-$40.6K	1.12%	30
2022 Q1	$764K	Hold	4,908	–	–	0.99%	30
2021 Q4	$625K	Buy	+4,908	New	+$645K	0.82%	35

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Eagle Harbor Asset Management's JAZZ Position: Q2 2026 in Review

Eagle Harbor Asset Management reduced its Jazz Pharmaceuticals (JAZZ) stake by 4.4% in Q2 2026, selling an estimated $32K and leaving 3,166 shares worth $763K. The position accounts for 0.6% of the portfolio, ranked #49.

Eagle Harbor Asset Management first reported a position in JAZZ in Q4 2021 and has held it in 19 quarters since. The position peaked at $764K in Q1 2022. 639 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Eagle Harbor Asset Management held 3,166 shares of Jazz Pharmaceuticals worth $763K as of Q2 2026.
Eagle Harbor Asset Management sold 146 Jazz Pharmaceuticals shares in Q2 2026, an estimated $32K.
Jazz Pharmaceuticals made up 0.6% of Eagle Harbor Asset Management's portfolio in Q2 2026, its #49 holding.
Eagle Harbor Asset Management first reported a position in Jazz Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
Eagle Harbor Asset Management's Jazz Pharmaceuticals position peaked at $764K in Q1 2022.
639 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Eagle Harbor Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.